Gut

HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS REGISTER
[Advanced]

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this link to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Add article to my folders
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Lundin, K E A
Right arrow Articles by Kett, K
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Lundin, K E A
Right arrow Articles by Kett, K
Gut 2003;52:1649-1652
© 2003 by BMJ Publishing Group Ltd & British Society of Gastroenterology


CASE REPORT

Oats induced villous atrophy in coeliac disease

K E A Lundin1, E M Nilsen2, H G Scott3, E M Løberg4, A Gjøen5, J Bratlie6, V Skar7, E Mendez8, A Løvik1, K Kett1

1 Department of Medicine, Rikshospitalet, Oslo, Norway
2 LIIPAT, Institute of Pathology, Rikshospitalet and University of Oslo, Oslo, Norway
3 Department of Pathology, Rikshospitalet, Oslo, Norway
4 Department of Pathology, Ullevaal University Hospital, Oslo, Norway
5 Department of Medicine, Ullevaal University Hospital, Oslo, Norway
6 Institute for Medical Research, Rikshospitalet and University of Oslo, Oslo, Norway
7 Department of Medicine, Lovisenberg Hospital, Oslo, Norway
8 Unidad de Analisis Estructural Proteinas, Centro Nacional de Biotechnologica, CSIC, Madrid, Spain

Correspondence to:
Correspondence to:
Dr K E A Lundin
Department of Medicine, Rikshospitalet, N-0027 Oslo, Norway; knut.lundin{at}rikshospitalet.no


ABSTRACT
The current trend is to allow coeliac disease (CD) patients to introduce oats to their gluten free diet. We sought further data from the clinical setting with regards to oats consumption by coeliac patients. Several oat products were tested for wheat contamination using a commercial enzyme linked immunoassay (ELISA) kit, and six samples were examined by an ELISA using a cocktail of monoclonal antibodies, mass spectrometry, and western blot analysis. Nineteen adult CD patients on a gluten free diet were challenged with 50 g of oats per day for 12 weeks. Serological testing and gastroduodenoscopy was performed before and after the challenge. Biopsies were scored histologically and levels of mRNA specific for interferon {gamma} were determined by reverse transcription-polymerase chain reaction analysis. Oats were well tolerated by most patients but several reported initial abdominal discomfort and bloating. One of the patients developed partial villous atrophy and a rash during the first oats challenge. She subsequently improved on an oats free diet but developed subtotal villous atrophy and dramatic dermatitis during a second challenge. Five of the patients showed positive levels of interferon {gamma} mRNA after challenge. Some concerns therefore remain with respect to the safety of oats for coeliacs.


Keywords: coeliac disease; oats; clinical challenge; inflammation; villous atrophy

Abbreviations: CD, coeliac disease; ELISA, enzyme linked immunoassay; RNA, ribonucleic acid; RT-PCR, reverse transcription-polymerase chain reaction; IFN-{gamma}, interferon {gamma}; ppm, parts per million; MS, mass spectrometry; AGA, antigliadin antibodies; tTG, tissue transglutaminase; EMA, antiendomysium antibodies




This article has been cited by other articles:


Home page
Postgrad. Med. J.Home page
N Y Haboubi, S Taylor, and S Jones
Coeliac disease and oats: a systematic review.
Postgrad. Med. J., October 1, 2006; 82(972): 672 - 678.
[Abstract] [Full Text] [PDF]


Home page
GutHome page
D A van Heel and J West
Recent advances in coeliac disease
Gut, July 1, 2006; 55(7): 1037 - 1046.
[Full Text] [PDF]


Home page
NEJMHome page
L. Spaenij-Dekking, Y. Kooy-Winkelaar, and F. Koning
The Ethiopian cereal tef in celiac disease.
N. Engl. J. Med., October 20, 2005; 353(16): 1748 - 1749.
[Full Text] [PDF]


Home page
J. Immunol.Home page
T. Zheng, M. J. Kang, K. Crothers, Z. Zhu, W. Liu, C. G. Lee, L. A. Rabach, H. A. Chapman, R. J. Homer, D. Aldous, et al.
Role of Cathepsin S-Dependent Epithelial Cell Apoptosis in IFN-{gamma}-Induced Alveolar Remodeling and Pulmonary Emphysema
J. Immunol., June 15, 2005; 174(12): 8106 - 8115.
[Abstract] [Full Text] [PDF]


Home page
GutHome page
E H A Spaenij-Dekking, E M C Kooy-Winkelaar, W F Nieuwenhuizen, J W Drijfhout, and F Koning
A novel and sensitive method for the detection of T cell stimulatory epitopes of {alpha}/{beta}- and {gamma}-gliadin
Gut, September 1, 2004; 53(9): 1267 - 1273.
[Abstract] [Full Text] [PDF]


Home page
GutHome page
L Hogberg, P Laurin, K Falth-Magnusson, C Grant, E Grodzinsky, G Jansson, H Ascher, L Browaldh, J-A Hammersjo, E Lindberg, et al.
Oats to children with newly diagnosed coeliac disease: a randomised double blind study
Gut, May 1, 2004; 53(5): 649 - 654.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS REGISTER
Terms and conditions relating to subscriptions purchased online  ¦  Website terms and conditions  ¦  Privacy policy
Copyright © 2003 BMJ Publishing Group Ltd & British Society of Gastroenterology